These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11579374)

  • 21. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.
    Calin A; Garrett S; Whitelock H; Kennedy LG; O'Hea J; Mallorie P; Jenkinson T
    J Rheumatol; 1994 Dec; 21(12):2281-5. PubMed ID: 7699629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Costs and quality of life of patients with ankylosing spondylitis in Hong Kong.
    Zhu TY; Tam LS; Lee VW; Hwang WW; Li TK; Lee KK; Li EK
    Rheumatology (Oxford); 2008 Sep; 47(9):1422-5. PubMed ID: 18635597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of fatigue in the management of patients with ankylosing spondylitis.
    Dernis-Labous E; Messow M; Dougados M
    Rheumatology (Oxford); 2003 Dec; 42(12):1523-8. PubMed ID: 13130145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly.
    Braun J; McHugh N; Singh A; Wajdula JS; Sato R
    Rheumatology (Oxford); 2007 Jun; 46(6):999-1004. PubMed ID: 17389658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinal mobility in ankylosing spondylitis: reliability, validity and responsiveness.
    Haywood KL; Garratt AM; Jordan K; Dziedzic K; Dawes PT
    Rheumatology (Oxford); 2004 Jun; 43(6):750-7. PubMed ID: 15163832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Spondyloarthropathies--clinical evaluation and physical therapy].
    Vlak T
    Reumatizam; 2004; 51(2):29-33. PubMed ID: 15554374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The BASDAI-D--an instrument to defining disease status in ankylosing spondylitis and related diseases].
    Bönisch A; Ehlebracht-König I
    Z Rheumatol; 2003 Jun; 62(3):251-63. PubMed ID: 12827402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Living with a fluctuating illness of ankylosing spondylitis: a qualitative study.
    Mengshoel AM
    Arthritis Rheum; 2008 Oct; 59(10):1439-44. PubMed ID: 18821643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatigue in patients with ankylosing spondylitis: A comparison with the general population and associations with clinical and self-reported measures.
    Dagfinrud H; Vollestad NK; Loge JH; Kvien TK; Mengshoel AM
    Arthritis Rheum; 2005 Feb; 53(1):5-11. PubMed ID: 15696569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A patient's perspective on multidisciplinary treatment gain for fibromyalgia: an indicator for pre-post treatment effects?
    van Koulil S; Kraaimaat FW; van Lankveld W; van Riel PL; Evers AW
    Arthritis Rheum; 2009 Dec; 61(12):1626-32. PubMed ID: 19950305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hungarian adaptation of a disease-specific quality-of-life questionnaire in patients with ankylosing spondylitis].
    Lovas K; Géher P; Whalley D; McKenna S; Meads D; Kaló Z
    Orv Hetil; 2002 Aug; 143(32):1893-7. PubMed ID: 12221995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measures to assess ankylosing spondylitis: taxonomy, review and recommendations.
    Bakker C; Boers M; van der Linden S
    J Rheumatol; 1993 Oct; 20(10):1724-30. PubMed ID: 8295185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Responsiveness and discriminative capacity of the assessments in ankylosing spondylitis disease-controlling antirheumatic therapy core set and other outcome measures in a trial of etanercept in ankylosing spondylitis.
    Wanders AJ; Gorman JD; Davis JC; Landewe RB; van der Heijde DM
    Arthritis Rheum; 2004 Feb; 51(1):1-8. PubMed ID: 14872448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.
    Brandt J; Khariouzov A; Listing J; Haibel H; Sörensen H; Grassnickel L; Rudwaleit M; Sieper J; Braun J
    Arthritis Rheum; 2003 Jun; 48(6):1667-75. PubMed ID: 12794835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease and psychological status in ankylosing spondylitis.
    Martindale J; Smith J; Sutton CJ; Grennan D; Goodacre L; Goodacre JA
    Rheumatology (Oxford); 2006 Oct; 45(10):1288-93. PubMed ID: 16595514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life in patients with ankylosing spondylitis.
    Ward MM
    Rheum Dis Clin North Am; 1998 Nov; 24(4):815-27, x. PubMed ID: 9891712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of functional impairment in ankylosing spondylitis: impairment, activity limitation, and participation restrictions.
    Dagfinrud H; Kjeken I; Mowinckel P; Hagen KB; Kvien TK
    J Rheumatol; 2005 Mar; 32(3):516-23. PubMed ID: 15742446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognosis in ankylosing spondylitis].
    Diethelm U; Schüler G
    Schweiz Rundsch Med Prax; 1991 May; 80(21):584-7. PubMed ID: 2052823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis.
    van Denderen JC; van der Paardt M; Nurmohamed MT; de Ryck YM; Dijkmans BA; van der Horst-Bruinsma IE
    Ann Rheum Dis; 2005 Dec; 64(12):1761-4. PubMed ID: 15901634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A three-week multidisciplinary in-patient rehabilitation programme had positive long-term effects in patients with ankylosing spondylitis: randomized controlled trial.
    Kjeken I; Bø I; Rønningen A; Spada C; Mowinckel P; Hagen KB; Dagfinrud H
    J Rehabil Med; 2013 Mar; 45(3):260-7. PubMed ID: 23138412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.